Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.
- Provides an overview of an array of nanotechnology-based drug delivery systems
- Examines the design, synthesis and application of different nanocarriers in drug and gene delivery
- Provides an in-depth understanding of the design of targeted nanotherapeutics and technologies and its implication in various site-specific cancers
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
ISBN-13
978-0-12-816367-2 (9780128163672)
Schweitzer Klassifikation
1. Introduction: An Overview of the anatomy and physiology of the lung2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug Resistance3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancer4. Polymeric nanoparticles based drug delivery for lung cancer5. Solid lipid nanoparticles based drug delivery for lung cancer6. Liposomes and niosomes based drug delivery for lung cancer7. Dendrimers based drug delivery for lung cancer8. Micelles based drug delivery for lung cancer9. Nanoemulsions based drug delivery for lung cancer10. Nanomedicine-based inhalation treatments for lung cancer11. Towards development of novel diagnostic nano-imaging platform for lung cancer12. Hydrogel based drug delivery for lung cancer13. Quantum dots based drug delivery for lung cancer
